Camille Taillé

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study

Marc Humbert, Camille Taillé, Laurence Mala et al. · European Respiratory Journal · 2018 · 270 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Eosinophilic and Noneosinophilic Asthma

Liam G. Heaney, Luis Pérez de Llano, Mona Al‐Ahmad et al. · CHEST Journal · 2021 · 265 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Bilirubin decreases NOS2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats

Sophie Lanone, Sébastien Bloc, Roberta Foresti et al. · The FASEB Journal · 2005 · 260 citations

Life Sciences, Pharmacology, Physiology +13

Mitochondrial Respiratory Chain and NAD(P)H Oxidase Are Targets for theAntiproliferative Effect of Carbon Monoxide in Human Airway SmoothMuscle

Camille Taillé, Jamel El‐Benna, Sophie Lanone et al. · Journal of Biological Chemistry · 2005 · 245 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17